Literature DB >> 1390239

Mixed phenotype of blasts in acute megakaryocytic leukaemia and transient abnormal myelopoiesis in Down's syndrome.

K Yumura-Yagi1, J Hara, H Kurahashi, T Nishiura, Y Kaneyama, Y Osugi, N Sakata, M Inoue, A Tawa, S Okada.   

Abstract

Blasts from eight cases with acute megakaryoblastic leukaemia (AMKL) and seven with transient abnormal myelopoiesis in Down's syndrome (TAM) were investigated to clarify their phenotypic characteristics. CD41 and CD7 were the most frequently expressed in both disorders. CD41 was positive in six TAM and five AMKL cases, and CD7 was positive in five TAM and five AMKL cases, respectively. CD33 was detected in four TAM and five AMKL cases. Other myeloid-lineage associated antigens such as CD13 and CD11b could not be found in TAM but were expressed in five AMKL cases. Interestingly, CD56, a neural adhesion molecule, was expressed in three of four TAM and one of five AMKL cases. Cytoplasmic CD3 antigen was also noted in three of five examined cases. A short-term culture study was conducted on blasts from two TAM cases and five AMKL cases. In two cases in which CD41 was not expressed before culture, the expression of CD41 was enhanced after culture with or without 12-O-tetradecanoyl-phorbol-13-acetate (TPA). The expression of CD7 remarkably was depressed, while that of CD13 was enhanced after culture with TPA. These findings suggest that blasts of TAM and AMKL originate from very immature cells and represent a mixed phenotype. In the present study, distinction of phenotypical differences between blast in TAM and AMKL was not possible.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1390239     DOI: 10.1111/j.1365-2141.1992.tb02985.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Hematopoietic disorders in Down syndrome.

Authors:  John K Choi
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 2.  Myeloid leukemia in Down syndrome.

Authors:  Irum Khan; Sébastien Malinge; John Crispino
Journal:  Crit Rev Oncog       Date:  2011

3.  Multiparametric Flow Cytometry in Mixed Phenotype Acute Leukemia.

Authors:  Sindhura Lakshmi Koulmane Laxminarayana; Nishika Madireddy; Chethan Manohar; Karthik Udupa
Journal:  Indian J Hematol Blood Transfus       Date:  2019-02-13       Impact factor: 0.900

4.  Modeling Down Syndrome Myeloid Leukemia by Sequential Introduction of GATA1 and STAG2 Mutations in Induced Pluripotent Stem Cells with Trisomy 21.

Authors:  Sonali P Barwe; Aimy Sebastian; Ishnoor Sidhu; Edward Anders Kolb; Anilkumar Gopalakrishnapillai
Journal:  Cells       Date:  2022-02-11       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.